Hepatocellular carcinoma treated by sorafenib with complete radiological response according to mRECIST criteria: Could we stop the treatment? About four cases.
A letter to the editor is presented related to several case reports of patients diagnosed with hepatocellular carcinoma and treated with sorafenib achieving a radiological response in accordance to modified Response Evaluation Criteria in Solid Tumors.
No Comments.